Fig. 1From: Integrated investigation of the clinical implications and targeted landscape for RNA methylation modifications in hepatocellular carcinomaFlowchart of this study. The expression and mutation features of RNA methylated modification writers were investigated in 5 HCC datasets. Following clustering algorithms, a RNA methylation-based model was constructed to forecast tumor microenvironment alterations, immunotherapy response, targeted drug sensitivity, and survival status of HCC individualsBack to article page